DCF — TILLAMOOK REGIONAL MEDICAL CENTER
Enterprise Value: $13.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$13.1M
Enterprise Value
$1.1M
PV of Cash Flows
$12.0M
PV of Terminal Value
$19.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $109.9M | $3.9M | 4.0% | $-1.0M | $-0.9M |
| Year 2 | $113.2M | $5.2M | 5.0% | $-0.2M | $-0.2M |
| Year 3 | $116.6M | $6.5M | 6.0% | $0.7M | $0.5M |
| Year 4 | $120.1M | $7.3M | 6.0% | $1.1M | $0.8M |
| Year 5 | $123.7M | $7.8M | 6.0% | $1.4M | $0.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $13.1M. Terminal value accounts for 92% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$106.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.030811750069433156
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5